Understanding DEA and State Positions on Prescribing Controlled Medication During the COVID-19 Public Health Emergency
Paradigm Labs is doing its part to support healthcare providers and their patients during the COVID-19 Public Health Emergency (COVID-19 PHE). To this end, Paradigm Labs has developed a drug testing platform that allows providers and patients to engage in oral fluid drug testing facilitated by a telemedicine “visit.”
The U.S. Drug Administration has activated the public health emergency provision of the Ryan Haight Act, thereby allowing DEA registrants to prescribe controlled substances without an in-person medical exam of the patient for the duration of COVID-19 PHE and subject to the additional requirements set forth below. If you have questions about prescribing controlled substances via telemedicine in your state, contact your licensing board and/or legal counsel.
Link to March 2020 Arizona State Brief.
Link to March 2020 Georgia State Brief.
Link to March 2020 North Carolina State Brief.
Link to March 2020 South Carolina State Brief.